Announcing the #UromigosLive2024 #UromigosCup competition to select 1 team to come to Nashville and participate in the🏆. Repost with a picture, team name & support statement to enter. 3-4 teams will then participate in a podcast quiz to pick the winner. Deadline is June 7th.

Uromigos fantastic experience to join Tanya Dorff Sumanta K. Pal, MD, FASCO #TeamLA to win #Uromigoscup in 2023!Can’t wait for #UromigosLive2024 learned a lot from all teams! Toni Choueiri, MD Rana McKay Jonathan Rosenberg MD Brian Rini, MD Shilpa Gupta #McDermott
Fred Hutchinson Cancer Center Dimitra Bakaloudi MD, MS Michael Morris UroToday.com

Silke Gillessen summaries the #APCCC meeting in Lugano on our most recent podcast podcasters.spotify.com/pod/show/the-u…

Silke Gillessen summaries the #APCCC meeting in Lugano on our most recent podcast podcasters.spotify.com/pod/show/the-u…

Announcing the #UromigosLive2024 #UromigosCup competition to select 1 team to come to Nashville and participate in the🏆. Repost with a picture, team name & support statement to enter. 3-4 teams will then participate in a podcast quiz to pick the winner. Deadline is June 7th.

Chris Sweeney leads a quickfire podcast on bone health, hot flashes and Gynecomastia, with Matt Smith, Anthony Joshua and Lisa Horvath respectively podcasters.spotify.com/pod/show/the-u…

Have a listen to our podcast about the risk of cardiovascular disease with ADT in prostate cancer #APCCC24 Thomas Suter and Chuck Ryan are quizzed about it’s relevance and which tests are needed. podcasters.spotify.com/pod/show/the-u…

APCCC debate with Thomas Zilli and Pierre Blanchard covering radiation therapy for metastatic disease from Lugano. Thanks to Neeraj Agarwal, MD, FASCO for help with the tweet. #APCCC2024 OncoAlert . t.ly/D7N0_

Check out our APCCC podcasts with Jason Efstathiou and Piet Ost discuss the data for and against adjuvant radiotherapy. podcasters.spotify.com/pod/show/the-u…

Just out in ESMO open ESMO - Eur. Oncology With 44.0 months of median follow-up nivolumab/cabozantinib continues to outperform sunitinib in M1 clear cell RCC. The 3 VEGF/TKI combinations have more similarities than differences and track each other with longer follow up gbr01.safelinks.protection.outlook.com/?url=https%3A%…

Singapore Translational Cancer Consortium & Mount Sinai Hospital joining the IMCORE cancer research collaboration of 27 cancer centres & Roche. 96 cancer research project with >2000 scientists/HCPs and many high impact publications.Asian expansion reflects the global network

Everything you wanted to know about thr POUT trial but were after to ask Brian Rini, MD 💙alison birtle Tom Powles podcasters.spotify.com/pod/show/the-u…

Sumanta K. Pal, MD, FASCO Uromigos Tanya Dorff Petros Grivas Brian Rini, MD Tom Powles Renee Maria Saliby Toni Choueiri, MD Neeraj Agarwal, MD, FASCO Rana McKay Dan George Regina Barragan-Carrillo Nazli Dizman Matt Galsky Congrats again to the winning team and the fearless leader! Tanya Dorff

Congrats to Team L.A. Sumanta K. Pal, MD, FASCO Tanya Dorff and Petros Grivas for the inaugural #UromigosCup ! Enjoy your time with the Cup. Send pictures we miss it. 😢

ctDNA analysis in IM011 screening population #EAU24 Matt Galsky podcasters.spotify.com/pod/show/the-u…

Adjuvant nivo #EAU24 Matt Galsky podcasters.spotify.com/pod/show/the-u…

Serial ctDNA testing from IMVIGOR11 (post cystectomy in muscle invasive bladder cancer) show that ctDNA-ve patients (n=171) with a minimum of 12months follow up have 10% relapse rates and almost no deaths #EAU24 . Do we need to give adjuvant therapy to those as such low risk?

Part 2 of bladder sparing approaches in muscle invasive bladder cancer Michiel van der Heijden - new drugs, utDNA, ctDNA and radiotherapy could change everything. Will we need adjuvant therapy? podcasters.spotify.com/pod/show/the-u…

The results of the EV-302 trial, which reported improved OS & DFS for patients with mUC treated with 1L EV+P over chemo, could be 'the moon landing' for anyone who cares for patients with UC. Joshua Meeks explains for #ASCODailyNews : brnw.ch/21wIk4x #gucsm

This one doesn’t disappoint⁩. Crushed a bit by ⁦Matt Galsky⁩ biomarker comment “if you know the future predicting the future isn’t helpful” ⁦Tom Powles⁩ ⁦⁦Brian Rini, MD⁩ podcasts.apple.com/us/podcast/the…